Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

Clinical trial NCT05086744 · TERMINATED

Trial details

NCT number: NCT05086744
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)Cold Agglutinin Disease (CAD)

Start date: 2021-12-21
Primary completion: 2023-09-20
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.